204 related articles for article (PubMed ID: 33180250)
1. The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study.
Hunt TL; Tzanis E; Bai S; Manley A; Chitra S; McGovern PC
Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):85-92. PubMed ID: 33180250
[TBL] [Abstract][Full Text] [Related]
2. Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics.
Rodvold KA; Burgos RM; Tan X; Pai MP
Clin Pharmacokinet; 2020 Apr; 59(4):409-425. PubMed ID: 31773505
[TBL] [Abstract][Full Text] [Related]
3. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.
Tzanis E; Manley A; Villano S; Tanaka SK; Bai S; Loh E
J Clin Pharmacol; 2017 Mar; 57(3):321-327. PubMed ID: 27539539
[TBL] [Abstract][Full Text] [Related]
4. Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.
Bundrant LA; Tzanis E; Garrity-Ryan L; Bai S; Chitra S; Manley A; Villano S
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180524
[TBL] [Abstract][Full Text] [Related]
5. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function.
Berg JK; Tzanis E; Garrity-Ryan L; Bai S; Chitra S; Manley A; Villano S
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158281
[TBL] [Abstract][Full Text] [Related]
7. Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
Sun H; Ting L; Machineni S; Praestgaard J; Kuemmell A; Stein DS; Sunkara G; Kovacs SJ; Villano S; Tanaka SK
Antimicrob Agents Chemother; 2016 Dec; 60(12):7431-7435. PubMed ID: 27736760
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline.
Rodvold KA; Pai MP
Clin Infect Dis; 2019 Aug; 69(Suppl 1):S16-S22. PubMed ID: 31367744
[TBL] [Abstract][Full Text] [Related]
9. Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjects.
Härtter S; Sennewald R; Nehmiz G; Reilly P
Br J Clin Pharmacol; 2013 Apr; 75(4):1053-62. PubMed ID: 22946890
[TBL] [Abstract][Full Text] [Related]
10. Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.
O'Riordan W; Cardenas C; Shin E; Sirbu A; Garrity-Ryan L; Das AF; Eckburg PB; Manley A; Steenbergen JN; Tzanis E; McGovern PC; Loh E;
Lancet Infect Dis; 2019 Oct; 19(10):1080-1090. PubMed ID: 31474458
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.
Gotfried MH; Horn K; Garrity-Ryan L; Villano S; Tzanis E; Chitra S; Manley A; Tanaka SK; Rodvold KA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696233
[TBL] [Abstract][Full Text] [Related]
12. An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline.
Kovacs SJ; Ting L; Praestgaard J; Sunkara G; Sun H; Stein DS; Tanaka SK; Villano S
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839218
[TBL] [Abstract][Full Text] [Related]
13. Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
Cho JC; Childs-Kean LM; Zmarlicka MT; Crotty MP
Drugs Today (Barc); 2018 Mar; 54(3):209-217. PubMed ID: 29771255
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.
Choi DH; Chung JH; Choi JS
Eur J Clin Pharmacol; 2010 Mar; 66(3):285-90. PubMed ID: 20012601
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.
Sakugawa T; Miura M; Hokama N; Suzuki T; Tateishi T; Uno T
Br J Clin Pharmacol; 2009 May; 67(5):535-40. PubMed ID: 19552748
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
17. Omadacycline: A New Tetracycline Antibiotic.
Dougherty JA; Sucher AJ; Chahine EB; Shihadeh KC
Ann Pharmacother; 2019 May; 53(5):486-500. PubMed ID: 30917674
[TBL] [Abstract][Full Text] [Related]
18. Omadacycline: A Modernized Tetracycline.
Gallagher JC
Clin Infect Dis; 2019 Aug; 69(Suppl 1):S1-S5. PubMed ID: 31367739
[TBL] [Abstract][Full Text] [Related]
19. Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.
Choi DH; Shin WG; Choi JS
Eur J Clin Pharmacol; 2008 May; 64(5):445-9. PubMed ID: 18193210
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein Substrates.
Luffer-Atlas D; Wilbraham D; Posada MM; Landry J; Tsai M; Pearlman EM
J Clin Pharmacol; 2024 Jan; 64(1):94-102. PubMed ID: 37566903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
